Quality patient care and pharmacists' role in its continuity - A systematic review

Annals of Pharmacotherapy

Volumn 43, Issue 4, 2009, Pages 677-691

  Ellitt, Glena R ^a   Brien, Jo Anne E ^a,b   Aslani, Parisa ^a   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cardiovascular disease; Continuity of care; Depression; Diabetes; Medications; Pharmacist

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DYSLIPIDEMIA; DYSTHYMIA; HEALTH CARE COST; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HEART DISEASE; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LONG TERM CARE; LUNG DISEASE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PHARMACIST; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CONTINUITY OF PATIENT CARE; HUMANS; PATIENT CARE; PHARMACISTS; PROFESSIONAL ROLE; QUALITY OF HEALTH CARE;

EID: 65749089067     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L505     Document Type: Article

References (58)

1. Korcok M. US family physicians battling for their livelihood. Can Med Assoc J 1983;129:1223-1226 (Pubitemid 14206217)
2. Stewart M. Continuity, care, and commitment: the course of patient-clinician relationships. Ann Fam Med 2004;2:388-390 DOI 10.1370/afm.236
3. DeMaeseneer JM, DePrins L, Gosset C, Heyerick J. Provider continuity in family medicine: does it make a difference for total health care costs? Ann Fam Med 2003;1:144-148
4. Saultz JW. Defining and measuring interpersonal continuity of care. Ann Fam Med 2003;1:134-143 DOI 10.1370/afm.23
5. Holland DE, Harris MR. Discharge planning, transitional care, coordination of care, and continuity of care: clarifying concepts and terms from the hospital perspective. Home Health Care Services Quarterly (The Haworth Press Inc) 2007;26:3-19.
6. Haggerty J, Burge F, Levesque J-F, et al. Operational definitions of attributes of primary health care: consensus among Canadian experts. Ann Fam Med 2007;5:336-344 DOI 10.1370/afm.682
7. Freeman GK, Horder JP, Howle JG, et al. Evolving general practice consultation in Britain: issues of length and context (primary care). Br Med J 2002;324:880-883 DOI 10.1136/bmj.324.7342.880
8. Hjortdahl P. Ideology and reality of continuity of care. Fam Med 1990;22:361-364 (Pubitemid 20317510)
9. Hibberd PA. The primary/secondary interface. Cross-boundary teamwork - missing link for seamless care? J Clin Nurs 1998;7:274-282 DOI 10.1046/j.1365-2702.1998.00233.x
10. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. Br Med J 2003;327:1219-1221 DOI 10.1136/bmj.327.7425.1219 (Pubitemid 37465211)
11. Helleso R, Lorensen M. Inter-organizational continuity of care and the electronic patient record: a concept development. Int J Nurs Stud 2005; 42:807-822 DOI 10.1136/bmj.327.7425.1219 (Pubitemid 41104914)
12. Vuong T, Marriott J. Potential role of the community liaison pharmacist: stakeholder views. Int J Pharmacy Practice 2006;14:135-148 DOI 10.1211/ijpp.14.2.0008 (Pubitemid 43799507)
13. Kuehl AK, Chrischilles EA, Sorofman BA. System for exchanging information among pharmacists in different practice environments. J Am Pharm Assoc 1998;38:317-324
14. Cochrane Collaboration Group. Effective practice and organisation of care review: Epoc. The data collection checklist. Series Editors L McAuley and C Ramsay. Ottawa: Institute of Population Health, 2002.
15. National Health Service. Undertaking systematic reviews of research on effectiveness. CRD guidelines for those carrying out or commissioning reviews. CRD Report 4. York Y01 5DD: University of York, York Publishing Services Ltd., 1996.
16. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-694
17. Bravata DM, McDonald KM, Shojania KG, Sundarman V, Owens DK. Challenges in systematic reviews: synthesis of topics related to the delivery, organization, and financing of health care. Ann Intern Med 2005;142:1056-1065 (Pubitemid 40847708)
18. Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004;1:176-184 DOI 10.1111/j.1524-475X.2004.04006.x
19. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993;15:1121-32; discussion 20.
20. Gunter MJ. The role of the ECHO model in outcomes research and clinical practice improvements. Am J Manag Care (Supplement) 1999;5:S217-24.
21. Turpin DL. CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews. Am J Orthod Dentofacial Orthop 2005;128:681-686 DOI 10.1016/j.ajodo.2005.10.010
22. Glasziou P, Irwig L, Bain C, Colditz G. Systematic reviews in health care: a practical guide. United Kingdom: Cambridge University Press, 2001.
23. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Getting research findings into practice: closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. Br Med J 1998;317:465-468 (Pubitemid 28368041)
24. Needleman I. A guide to systematic reviews. J Clin Periodontol 2002;29:6-9. DOI 10.1034/j.1600-051X.29.s3.15.x (Pubitemid 41719441)
25. Gray DP, Evans P, Sweeney K, et al. Towards a theory of continuity of care. J R Soc Med 2003;96:160-166 DOI 10.1258/jrsm.96.4.160
26. Bell S, McLachlan AJ, Aslani P, Whitehead P, Chen TF. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Australia and New Zealand Health Policy 2005;2:29-40. DOI 10.1186/1743-8462-2-29
27. Boudreau DM, Capoccia KL, Sullivan SD, et al. Collaborative care model to improve outcomes in major depression. Ann Pharmacother 2002;36:585-591 DOI 10.1345/aph.1A259
28. Horowitz CR, Goldberg HI, Martin DP, et al. Conducting a randomized controlled trial of CQI and academic detailing to implement clinical guidelines. Jt Comm J Qual Improv 1996;22:734-750
29. Reeder CE, Dickson M, Kozma CM, Santell JP. ASHP national survey of pharmacy practice in acute care settings, 1996. Am J Health Syst Pharm 1997;54:653-669
30. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Reviewers Handbook 2001;CD001481. DOI 10.1002/14651858.CD001481
31. Santell JP. ASHP national survey of hospital-based pharmaceutical services - 1994. Am J Health Syst Pharm 1995;52:1179-1198
32. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Task force on economic evaluation of clinical pharmacy services of the American College of Clinical Pharmacy. Pharmacother 2003;23:113-132 DOI 10.1592/phco.23.1.113.31910
33. Vanscoy GJ. Outpatient management of venous thromboembolism. J Thromb Thrombolysis 1999;7:109-12. DOI 10.1023/A:1008821217432
34. Walker S, Willey CW. Impact on drug costs and utilization of a clinical pharmacist in a multisite primary care medical group. J Manag Care Pharm 2004;10:345-354
35. Whelan AM. Development of a Canadian family medicine pharmacy practice experience programme. J Clin Pharm Ther 2002;27:335-341 DOI 10.1046/j.1365-2710. 2002.00413.x
36. Worley-Louis MM, Schommer JC, Finnegan JR. Construct identification and measure development for investigating pharmacist-patient relationships. Patient Educ Couns 2003;51:229-38. DOI 10.1016/S0738-3991(02)00222-227
37. Zillich AJ, Doucette WR, Carter BL, Kreiter CD. Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health 2005;8:59-66. DOI 10.1111/j.1524-4733. 2005.03093.x
38. Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci 2004;26:114-120 DOI 10.1023/B:PHAR.0000018601.11248.89 (Pubitemid 38418601)
39. Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist co-management of hypertension: a randomized, comparative trial. Pharmacotherapy 2003;23:209-216
40. Brook O, van Hout H, Nieuwenhuyse H, Heerdink E. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol 2003;13:1-9. DOI 10.1016/S0924-977X(02)00074-83 (Pubitemid 35449731)
41. Bucci C, Jackevicius C, McFarlane K, Liu P. Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol 2003;19:391-396 (Pubitemid 36603506)
42. Bungay KM, Adler DA, Rogers WH, et al. Description of a clinical pharmacist intervention administered to primary care patients with depression. Gen Hosp Psychiatry 2004;26:210-218 DOI 10.1016/j.genhosppsych.2004.01.004
43. Capoccia KL, Boudreau DM, Blough DK, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm 2004;61:364-372
44. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004;2:257-264 DOI 10.1016/j.amjopharm.2005.01.001 (Pubitemid 40378780)
45. Dudas V, Bookwalter T, Kerr KM, Pantilat SZ. The impact of follow-up telephone calls to patients after hospitalization. Am J Med 2001;111:26S-30S. DOI 10.1016/S0011-5029(02)90031-90033 (Pubitemid 34085083)
46. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacother 2003;23:1175-1185 DOI 10.1592/phco.23.10.1175.32760
47. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:238-243 (Pubitemid 126497295)
48. Murray MD, Young JM, Morrow DG, et al. Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. Am J Geriatr Pharmacother 2004;2:53-65. DOI 10.1016/S1543-5946(04)90007-90014
49. Nickerson A, MacKinnon NJ, Roberts N, Saulnier L. Drug-therapy problems, inconsistencies and omissions identified during a medication reconciliation and seamless care service. Healthcare Quarterly 2005;8 Spec No:65-72.
50. Paulos CP, Nygren CEA, Celedon C, Carcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother 2005;39:939-943 DOI 10.1345/aph.1E347 (Pubitemid 40570674)
51. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005;118:276-284 DOI 10.1016/j.amjmed.2004.09.017
52. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol 1997;44:163-165 DOI 10.1046/j.1365-2125.1997.00629.x (Pubitemid 27327069)
53. Voirol P, Kayser SR, Chang CY, Chang QL, Youmans SL. Impact of pharmacists' interventions on the pediatric discharge medication process. Ann Pharmacother 2004;38:1597-1602 DOI 10.1345/aph.1E087 (Pubitemid 39297753)
54. Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 2003;169:17-22.
55. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial [erratum appears in Br J Clin Pharmacol 2005 Mar;59(3):376]. Br J Clin Pharmacol 2004;58:648-664 DOI 10.1111/j.1365-2125.2004.02220.x
56. Fischer LR, Defor TA, Cooper S, et al. Pharmaceutical care and health care utilization in an HMO. Eff Clin Pract 2002;5:49-57.
57. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002;54:657-664 DOI 10.1046/j.1365-2125.2002.01707.x (Pubitemid 36002595)
58. Eakin JM, Mykhalovski E. Reframing the evaluation of qualitative health research: reflections on a review of appraisal guidelines in the health sciences. J Eval Clin Pract 2003;9:187-194 DOI 10.1046/j.1365-2753.2003.00392.x